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Abstract
The aim of this paper is to develop a functional mixed effects modeling (FMEM) framework for 
the joint analysis of high-dimensional imaging data in a large number of locations (called voxels) 
of a three-dimensional volume with a set of genetic markers and clinical covariates. Our FMEM is 
extremely useful for effciently carrying out the candidate gene approaches in imaging genetic 
studies. FMEM consists of two novel components including a mixed effects model for modeling 
nonlinear genetic effects on imaging phenotypes by introducing the genetic random effects at each 
voxel and a jumping surface model for modeling the variance components of the genetic random 
effects and fixed effects as piecewise smooth functions of the voxels. Moreover, FMEM naturally 
accommodates the correlation structure of genetic markers at each voxel, while the jumping 
surface model explicitly incorporates the intrinsically spatial smoothness of the imaging data. We 
propose a novel two-stage adaptive smoothing procedure to spatially estimate the piecewise 
smooth functions, particularly the irregular functional genetic variance components, while 
preserving their edges among different piecewise-smooth regions. We develop weighted 
likelihood ratio tests and derive their exact approximations to test the effect of the genetic markers 
across voxels. Simulation studies show that FMEM significantly outperforms voxel-wise 
approaches in terms of higher sensitivity and specificity to identify regions of interest for carrying 
out candidate genetic mapping in imaging genetic studies. Finally, FMEM is used to identify brain 
regions affected by three candidate genes including CR1, CD2AP, and PICALM, thereby hoping 
to shed light on the pathological interactions between these candidate genes and brain structure 
and function.
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1 Introduction
Common mental and neurological disorders, such as autism and schizophrenia, are highly 
heritable and strongly associated with brain structure and function, but it has been diffcult to 
unravel the genetic factors of these complex illnesses in that many genetic factors may 
contribute to the susceptibility of the disease while the contribution of each factor is small. 
Since imaging data provide the most effective measures of brain function and structure, such 
data may serve as an important intermediate phenotype that ultimately can lead to 
discoveries of genes for these complex disorders. Imaging genetic studies, which collect 
both imaging and genetic data, have recently attracted extensive research interest for 
dissecting the genetic basis of neurological disorders [Gilmore and et al, 2010, Loth et al., 
2011, Savitz and Drevets, 2009]. The common and important themes of both the imaging 
and genetic data include ultra-high dimensionality and complex correlation structures 
determined by the physical location. However, most of the existing methods for genetic 
association studies focus on low dimensional phenotypes (e.g. case-control status) and thus 
cannot account for high-dimensional imaging phenotypes, while accounting for spatial 
smoothness of the imaging measurements. On the other hand, most existing association 
methods in the neuroimaging literature do not study the joint effects of multiple genetic 
markers, while accommodating their correlations due to linkage disequilibrium (LD).
There are two main genetic association approaches including i) the candidate gene 
approaches and ii) the genome-wide association studies (GWAS) for correlating imaging 
phenotype with genotype at one or more polymorphic markers in order to uncover genetic 
predispositions to disease [Zhu and Zhao, 2007, Amos et al., 2011]. Both approaches enjoy a 
combination of advantages and disadvantages. Candidate genes are commonly selected for 
study based on either a priori knowledge of their biological functional impact on the 
phenotype or disease in question or previous GWAS studies, such as the NHGRI GWAS 
catalog [Hindor et al., 2009]. The candidate gene approach tends to have rather high 
statistical power, but is incapable of discovering new genes or gene combinations. A 
standard statistical method for the candidate approach in imaging genetics is the voxel-wise 
analysis (VWA) framework. The voxel-wise analysis consists of Gaussian smoothing the 
imaging data and subsequently fitting a statistical model at each voxel. However, the voxel-
wise analysis is generally not optimal in power and the use of Gaussian smoothing may 
introduce a substantial bias in the statistical results [Jones et al., 2005, T. Ball et al., 2012, Li 
et al., 2011, 2013].
Most imaging genetic studies have used the candidate gene approach, although more 
recently, more studies are beginning to scan the entire genome for common genetic variation 
[Thompson et al., 2013, Zhang et al., 2014]. A standard statistical method for GWAS in 
imaging genetics is the massive univariate linear modelling (MULM) framework [Hibar and 
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et al, 2011, Shen et al., 2010]. This approach repeatedly fits a linear regression model for 
each pair of imaging voxels and genetic markers. MULM entails a large number of 
comparisons, and thus MULM can only detect extremely significant imaging-marker pairs. 
Moreover, MULM ignores both the spatial information of the imaging data and the 
correlation among genetic markers. See more detailed discussions in [Vounou et al., 2010, 
Ge et al., 2012, Thompson et al., 2013]. Recently, in Ge et al. [2012], a cluster-wide, marker 
set association framework was proposed by integrating cluster size inferences based on 
random field theory in order to utilize the spatial smoothness of the imaging data [Worsley 
et al., 2004] and a marker set analysis based on least-squares kernel machines in order to 
assess the joint association of potentially correlated and interacting loci [Liu et al., 2007].
The aim of this paper is to develop a functional mixed effects modeling (FMEM) framework 
for the joint analysis of high-dimensional imaging data with a set of genetic markers and 
clinical covariates. Our FMEM is extremely useful for effciently carrying out the candidate 
gene approaches in imaging genetic studies. FMEM consists of two novel components 
including a mixed effects model and a jumping surface model. Specifically, at each voxel, 
we use the mixed effects model with genetic random effects to assess the nonlinear 
association of potentially correlated and interacting loci with imaging phenotypes and the 
variance component (VC) of genetic random effects to detect the nonlinear effects of a 
marker set on imaging measures across voxels [Liu et al., 2007, Tzeng and Zhang, 2007, 
Wang and Chen, 2012]. To account for the spatial smoothness of the imaging data, we use 
the jumping surface model to explicitly model both the genetic variance component and 
fixed effects as piecewisel smooth functions of the voxels with unknown edges and possible 
jumps. We develop a novel two-stage adaptive smoothing procedure to spatially estimate the 
genetic variance component function, while preserving its edges among different piecewise-
smooth regions. We also develop weighted likelihood ratio tests and derive their exact 
approximations to test the effect of the genetic markers across the brain. Our numerical 
examples show that FMEM significantly outperforms voxel-wide approaches in terms of 
detection of meaningful effect regions.
The rest of the paper is organized as follows. In Section 2, we describe the proposed FMEM 
and its adaptive estimation procedure. Then, we develop our hypothesis testing procedure to 
assess the genetic effects as well as the effect of clinical variables on the imaging 
phenotypes. In Section 3, we evaluate the finite-sample performance of FMEM by using 
simulation studies and analyzing a real data set from the Alzheimer’s Disease Neuroimage 
Initiative (ADNI). A few concluding remarks are given in the Discussion section.
2 Methods
2.1 Functional Mixed Effects Model
Suppose that we observe imaging measures, clinical variables, and genetic markers from n 
unrelated subjects. Let  be the whole brain and v be a voxel in . For each individual i (i = 
1, …, n), an NV × 1 vector of imaging measures is observed and denoted by 
. For notational simplicity, we only consider univariate imaging 
measures and thus, NV equals the number of voxels in . Moreover, a K × 1 vector of 
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clinical covariates xi = (xi1, …xiK)T and a G × 1 vector gi = (gi1, …gig)T for genetic markers 
are also collected for each individual. For instance, imaging measures can be brain structural 
and functional data at each location [Friston, 2009, Ashburner and Friston, 2000], and 
genetic markers can be various polymorphism types, such as single nucleotide 
polymorphisms (SNPs), block substitutions, and copy number variants [Liu et al., 2007, 
Tzeng and Zhang, 2007, Wang and Chen, 2012]. The objective of this paper is to develop 
FMEM to quantify genetic contributions to high-dimensional imaging measures.
Our FMEM framework consists of two novel components including a mixed effects model 
(MEM) at each voxel and a jumping surface model (JSM) for varying coefficient functions 
across the brain. First, at each voxel v in , a mixed effects model is introduced as
(1)
where β(v) = (β1(v), …, βK(v))T is a K × 1 vector, , , 
and  are independent across subjects i and independent of γ(v) for all , 
in which IL is an identity matrix. Let Z = (z1, …,zn) be an L × n matrix and Y(v) = (y1(v), 
…, yn(v))T be an n × 1 vector. Thus, under model (1), we have
Model (1) can be regarded as an alternative representation of the variance component 
models used in the literature [Liu et al., 2007, Tzeng and Zhang, 2007, Kang et al., 2010, 
Wang and Chen, 2012]. For instance, when ZTZ equals a kernel matrix K = (K(gi, gi′)), 
model (1) reduces to the linear mixed model considered in [Liu et al., 2007, Ge et al., 2012], 
where K(·,·) is a kernel function, such as the polynomial kernel, identity-by-state (IBS) 
kernel, or the Gaussian kernel. For instance, the IBS kernel is used in [Ge et al., 2012].
Model (1) has a strong connection with a nonparametric fixed effects model given by
(2)
where h(·; v) is an unknown centered function corresponding to the genetic effects at voxel 
v. To estimate the unknown functions h(·; v) in model (2), a common approach is to express 
them as linear combinations of some pre-specified basis functions (e.g., splines or kernels), 
that is , where γ(v) = (γ1(v), …, γL(v))T is an L × 1 vector for genetic 
random effects and zi is a pre-specified L × 1 vector of functions of gi. The variation of h(gi; 
v) is then controlled by the variation of their basis coefficients in γ(v). Moreover, a penalty 
function (e.g., L2 or L1) coupled with a tuning parameter is usually introduced to impose 
certain constraints on γ(v) and such penalty function can be regarded as a prior distribution 
of random effects. Thus, this connection provides a simple way to connect the 
nonparametric fixed effects model (2) with model (1) [Liu et al., 2007, Tzeng and Zhang, 
2007, Kang et al., 2010, Wang and Chen, 2012]. We focus on model (1) from now on.
We also assume spatial correlation as follows. For v and v′ in , we assume
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where 1(·) is an indicator function and ρe(v, v′) characterizes the spatial correlation between 
the measurement errors. Therefore, the covariance structure of yi(v) is given by
(3)
Following Zhu et al. [2014], we propose a JSM for the genetic varying coefficient function 
 and the fixed effect varying coeffcient functions 
 for j = 1, …, K. For notational simplicity, we only introduce JSM 
for  as follows:
• (i) (Disjoint Partition) There is a finite and disjoint partition  of V 
such that .
• (ii) (Piecewise Smoothness)  is smooth within each  for l = 1, …, Lγ, but 
 is discontinuous on , where  is the boundary of  and the 
jumping surface of .
A similar JSM can be defined for each βj(·) for j = 1, …, K.
We use JSM to explicitly delineate the fact that imaging data  can be 
regarded as a noisy version of a piecewise-smooth function of  with the possible 
existence of jumps or edges. In many neuroimaging datasets, those jumps or edges often 
reflect the functional and/or structural changes, such as white matter (WM) and grey matter 
(GM), across the brain. Therefore, the varying coefficient functions in model (1) may inherit 
the piecewise-smooth features from the imaging data. Furthermore, it is more reasonable to 
assume that different varying coefficient functions have different jumps or edges, since they 
may play different roles in characterizing the piecewise-smooth pattern of the imaging data.
Our FMEM consisting of model (1) and JSM can be regarded as a novel extension of the 
existing FMEMs and varying coefficient models in the literature [Zhu et al., 2011, Yuan et 
al., 2014, Morris and Carroll, 2006, Guo, 2002, Greven et al., 2010, Zhu et al., 2014, 2012], 
even though all of them are developed to model functional responses (of time or voxel) 
measured either cross-sectionally or longitudinally. However, at each voxel, the jumping 
surface model is introduced to spatially characterize the piecewise smoothness of the 
imaging data. In contrast, most existing FMEMs and varying coefficient models reduce to a 
parametric model at each voxel, while most FMEMs do not explicitly model the piecewise 
smoothness of the imaging data. Moreover, the primary interest of our FMEM is to estimate 
the genetic varying coefficient function , whereas that of other FMEMs and varying 
coefficient models is to estimate the fixed effects varying coefficient functions βj(·). 
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Estimating the function  is computationally and theoretically much harder than 
estimating the varying coefficient functions, since  satisfies a nonnegative constraint.
2.2 Two-stage Estimation Procedure
We propose a two-stage estimation procedure to estimate all varying coefficient functions 
and test their effects on imaging phenotypes. The key ideas of each stage are given as 
follows:
Stage I. Estimate , develop an adaptive smoothing method to estimate , and 
test the null hypothesis  across all voxels.
Stage II. Develop an adaptive smoothing method to spatially and adaptively estimate 
 and then test associated hypotheses.
Moreover, after calculating ,  and , we can estimate 
, where  and X = (x1, 
…,xn) is a p × n matrix. To approximate ρe(v, v′), we calculate the empirical correlation 
between  and  where 
. Since γ(v) and ρe(v, v′) are nuisance parameters, we do 
not focus on them throughout. Since our primary interest lies in the genetic effect, we focus 
on Stage I and only briefly discuss Stage II for the sake of space.
The key novelty of our estimation procedure is the adaptive smoothing method in Stage I for 
smoothing . Since the true variance components σγ(v) can be zero in some regions of 
interest and their estimates are always non-negative, directly applying standard smoothing 
methods, such as splines or kernel smoothing, to these nonnegative variance component 
estimates can introduce substantial bias in the estimation of functional genetic variance 
components. Thus, most existing smoothing methods cannot be successfully used in such 
smoothing problems [Zhu et al., 2011, Yuan et al., 2014, Morris and Carroll, 2006, Guo, 
2002, Greven et al., 2010, Zhu et al., 2014, 2012, Polzehl and Spokoiny, 2000, Polzehl et al., 
2010, Yue et al., 2010].
2.2.1 Stage I—The first stage consists of three major steps as follows:
Step I.1. Calculate the restricted maximum likelihood (REML) estimator of 
 across all voxels .
Step I.2. Spatially and adaptively re-estimate  by incorporating 
information from neighboring voxels.
Step I.3. Construct weighted likelihood ratio statistics and derive their approximate 
distributions to test the null hypothesis of  across all voxels.
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In Step I.1, we calculate the REML estimator of η(v) across voxels. There exists an (n – p) × 
n matrix Kx such that KxXT = 0 and rank(Kx) = n – p. A mixed effects model for Y* (v) = 
KxY(v) is given by
(4)
where E(v) = (e1(v), …, en (v))T. Based on the distributional assumptions in (1), we have Y* 
(v) ~ N(0, ΣY* (v)), where . Thus, at each voxel 
v, the REML estimate of η(v), denoted by , is to maximize the 
REML function given by
(5)
Since our primary interest lies on , we fix  as  from here on.
In Step I.2, we construct a weighted REML function to estimate  by incorporating the 
spatial information in a neighborhood B(v, h) for each voxel v with a specific radius h as 
follows:
(6)
where ωγ (v, v′; h) is a weight function of voxels v, v′, and the radius h. We maximize 
 in order to calculate the weighted REML estimator of , 
denoted by . The weight function ωγ (v, v′; h) measures the data similarity between 
the two voxels v and v′ such that Σv′∈B(v,h)ωγ(v,v′; h) = 1 and ωγ (v, v′; h) ≥ 0. A large value 
of ωγ (v, v′; h) means that the information contained in the voxels v and v′ is very similar, 
whereas ωγ (v, v′; h) ≈ 0 indicates that the data in voxel v′ do not have too much information 
for σv (v). The adaptive weight ωγ (v, v′; h) plays a critical role in preventing over-smoothing 
estimation of  and preserving the edges of significant regions of .
In Step I.3, to assess the genetic effects on imaging phenotypes across all voxels, we 
formulate it as testing the following null and alternative hypotheses:
(7)
We test (7) by using the weighted REML ratio statistic defined by
(8)
Since all the subjects share the same random effect γ(v), the standard asymptotic results in 
Stram and Lee [1994] are invalid and can perform very poorly even for the unweighted 
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REML ratio statistics for testing random effects in model (1). However, we provide an exact 
null distribution of  below.
2.2.2 Step I.2 Adaptive Estimation of —Following the adaptive estimation 
(AET) procedure proposed in [Li et al., 2011], we adaptively determine 
 and then calculate  as h increases from h0 = 0 to a 
predetermined value hS = r0. The key novelty of AET is to build a sequence of 
 for h0 = 0 < h1 < … < hS = r0 at each voxel  and then 
sequentially determine ωγ (v, v′; hs) for all v′ ∈ B(v, hs) based on 
 for all  and s = 1, …, S. However, one cannot apply 
many existing smoothing methods, such as local kernel or the propagation-seperation 
method [Zhu et al., 2014, Polzehl and Spokoiny, 2000, Polzehl et al., 2010, Fan and Gijbels, 
1996], to directly smooth  in the non-activation region 
. Specifically, since  is always non-negative even in the 
voxels of , directly calculating the weighted means of  does not lead to the bias 
reduction in . A path diagram of AET is given as follows:
The three key steps of AET, including weight adaptation, estimation, and termination 
checking, are presented as follows.
• In the weight adaption step (i), we select a series  of radii with 
ch ∈ (1, 2), say ch = 1.125. We use a relatively small ch in order to increase 
estimation robustness and prevent oversmoothing. We then set s = 1 and h1 = ch. 
The adaptive weights in (6) are given by
(9)
where Kloc(u) = (1 – u)+ and Kst(u) = min(1, 2(1 – u2))+, and ∥·∥2 denotes the 
Euclidean norm of a vector (or a matrix). Moreover, Dγ (v, v′; hs−1) is set as 
 so that the difference between 
consecutive  is within the precision of , where 
 is estimated by using the inverse of the Fisher information matrix of 
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 from the likelihood function (5) with h = h0. We choose C = n1/3 
χ2(1)0.5 for Dγ (v, v′; hs−1) defined in (9), where χ2(1)0.5 is the 0.5-percentile of the 
χ2(1) distribution. These quantities are fixed for subsequent updates of hs.
The rationale for choosing different tuning parameters given above is given as follows. The 
weight Kst(Dγ (v, v′; hs−1)/Cn) downweights the role of a voxel v′ ∈ B(v, hs) in the REML 
functions if Dγ (v, v′; hs−1) is large. The weight Kloc(∥v – v′∥2/hs) gives less weight to the 
voxel v′ ∈ B(v, hs), whose location is far from the voxel v. The scale Cn is used to penalize 
the similarity between any two voxels v and v′ in a similar manner to bandwidth, and an 
appropriate choice of Cn is crucial for the behavior of the adaptive smoothing method in 
Stage I. As discussed in Zhu et al. [2014] and Li et al. [2011], Cn should satisfy Cn/n = o(1) 
and .
• In the estimation step (ii), for each  and for the radius hs given ωγ (v, v′; hs), 
we calculate  by maximizing  defined in 
equation (6).
• In the termination checking step (iii), after the S0–th iteration, we calculate a 
stopping criterion based on a distance between  and  given by
(10)
for s > S0. Then, we compare  with a benchmark, 
denoted by , for s > S0. If , then we set 
 and the estimation for this voxel v is terminated. If s = S and 
,  is set as  and the estimation 
process terminates. The algorithm stops when the estimation is finished for all v in 
V. If s ≤ S0 or  for s < S0 S – 1, then we go back 
to the weight adaptation step (i) with an increased radius . 
Throughout the paper, we set S0 = 2, , and S = 10. Note that 
 is a decreasing function in s which makes the stopping criteria more and more 
stringent when the radius increases in order to prevent over-smoothing.
2.2.3 Step I.3: Testing —We perform hypothesis testing in (7) by 
using the testing statistics  and their corresponding p-values. Let 
 be the spectral decomposition of such that D0 = diag(d1, …, dn-p) 
is the diagonal matrix of eigenvalues dk and U is an (n – p) × (n – p) orthonormal matrix. 
Without loss of generality, we choose Kx such that . We obtain the following 
theorem, whose proof is included in the supplementary document.
Theorem 1. Under model (1), RLRTn(v) can be written as
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where  and D(v′; t) is given by
(12)
Moreover, under the null hypothesis H0,γ, (v), we have
(13)
where  means equality in distribution and the δl(v)’s are i.i.d N(0, 1) random variables.
Although Theorem 1 provides an effcient way of approximating the null distribution of 
RLRTn(v), a complex issue arises from the complex spatial correlations among the 
across voxels v′ ∈ B(v, h). One approach for dealing with such an issue is to estimate the 
spatial correlation for any pair of voxels, which can be computationally intensive. To avoid 
calculating spatial correlations, we develop a wild bootstrap method to effciently simulate 
the null finite sample distribution of RLRTn(v). The detailed steps of this bootstrap method 
are presented in the supplementary document. After the p-values for all voxels  are 
computed, either a false discovery rate (FDR) method or random field theory (RFT) is 
applied to correct for multiple comparisons [Ge et al., 2012].
2.3 Stage II
The second stage is to estimate β(v) and carry out statistical inference on β(v). At each voxel 
v, we consider model (1) given by
(14)
After calculating , we can calculate 
. Since all components of β(v) and ΣY (v) are statistically 
orthogonal to each other, we fix ΣY (v) at  from here on. Since the true β(v) is not on 
the boundary of parameter space, different adaptive smoothing methods can be used here 
[Zhu et al., 2014, Polzehl and Spokoiny, 2000, Polzehl et al., 2010]. For simplicity, we put 
the detailed steps of Stage II in the supplementary document.
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We simulated data at all NV = 5, 808 voxels on a 44×44×3 phantom image. Each z-slice 
contains the same effect regions. At each voxel, we simulated the univariate imaging 
measures according to model (1) with β(v) = (β0(v), β1(v), β2(v), β3(v))T and xi = (1, xi1, xi2, 
xi3)T. Moreover, the covariates xi1, xi2, and xi3 were generated from a Gaussian distribution 
with mean 40 and standard deviation 10, a Bernoulli distribution with success probability 
0.5, and a Bernoulli distribution with success probability 0.3, respectively. These three 
covariates were designed to mimic the common clinical variables: age, gender, and disease 
status. For a slice of the phantom image, the effect areas for β0(v) were divided into 16 
regions with 4 different values ranging from 0.02 to 0.08, increasing by 0.02 (Figure 1(a)); 
for β1(v), the effect regions were divided into 25 regions ranging from 10−2.5 to 10−12.5, 
decreasing by a rate of 10−2.5 (Figure 1(b)); for β2(v), the whole space was separated into 3 
regions with values 0, 0.05, and 0.1 (Figure 1(c)); the effect area of β3(v) was divided into 9 
regions with values ranging from 0 to 0.1, increasing by differences of 0.025 (Figure 1(d)).
The genetic information was simulated according to the SNP data obtained from the public 
accessible data of the Alzheimer’s Disease Neuroimage Initiative (ADNI). It is an ongoing 
longitudinal study with the primary purpose of exploring the genetic and neuroimaing 
information associated with late-onset Alzheimer’s disease (LOAD). The study recruited 
elderly subjects older than 65 years of age consisting about 400 subjects with mild cognitive 
impairment (MCI), about 200 subjects with Alzheimer’s disease (AD), and around 200 
healthy controls. Each subject was followed for at least 3 years. During the study period, the 
subjects were assessed with magnetic resonance imaging (MRI) measures and psychiatric 
evaluation to determine the diagnosis status at each time point. Genetic information was also 
collected from each subject at baseline and is genotyped by the Illumina 610 Quad array 
with more than 620,000 single nucleotide polymorphisms (SNPs). More information on 
ADNI is provided in the real data analysis of Section 3.2. We simulated the genetic 
information based on the two following scenarios:
• Scenario I. To preserve the linkage disequilibrium among SNPs, we utilize all of 
the SNPs on chromosome 1 from 197 Caucasian controls to generate the genetic 
effects. After eliminating the SNPs with minor allele frequency (MAF) less than 
5%, there were 31554 out of 45627 SNPs left. Then, we randomly chose 20 SNPs 
and 100 subjects among the 197 healthy controls as the simulated genetic data zi in 
(1). In this case, n = 100. If any of these 20 SNPs have MAF less than 5%, then the 
genetic data was resampled until all of the 20 SNPs have MAF ≥ 5%.
• Scenario II. To evaluate the performance of FMEM in the case of high LD, we 
selected the SNPs from the same gene in the second scenario. Searching the SNPs 
on the gene PICALM, which has been found to be relevant for Alzheimer’s disease 
in many studies [Harold et al., 2009] using the gene list “glist-hg18” provided by 
PLINK, there were 23 SNPs on PICALM with MAF larger than 5%. After 
eliminating the missing values, there are 176 healthy controls with complete 
genotype data at these 23 SNPs. We randomly selected 7 SNPs from 75 healthy 
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controls to be zi in (1). Although there is strong LD among these 7 SNPs, no SNP 
has perfect correlation (1 or −1) with any other SNPs in these 75 subjects. In this 
case, n = 75.
In both scenarios, the SNP effects were assumed to be additive. The γ(v)’s were generated 
from a multivariate normal distribution with mean zero and covariance matrix . 
Different  values, which represent di erent signal-to-noise ratios, were chosen to 
examine the finite sample performance of our method at different signal-to-noise ratios and 
also to test whether FMEM can perform well for different shapes. See Figure 3 (b) and 
Figure 3 (e) for Scenarios I and II. Moreover, we overlay some of the effect areas of β3(v) 
and  in order to account for the fact that the brain phenotype is an intermediate 
expression of disease progression. The  of the effect regions in Scenario I 
ranged from 0.005 to 0.025, increasing by 0.0025, whereas the  of effect 
regions in Scenario II ranged from 0.005 to 0.045, increasing by 0.005. The random error 
ei(v) was independently distributed as a univariate normal distribution with mean 0 and 
standard deviation 3 for all voxels. We set the number of bootstrap samples M and the 
number of repetitions to be 200.
Tables 1 and 2 summarize the estimation results of  obtained from FMEM and the 
voxel-wise method for both scenarios. The tables include the average absolute value of the 
bias, the root mean square error (RMS), standard deviation (SD), and the ratio of RMS to 
SD. RMS is based on the empirical mean and the SD is based on the theoretical mean. As 
shown in both tables, FMEM produces smaller estimation bias, RMS, and SD compared 
with the voxel-wise method, which indicates that FMEM yields much more accurate 
estimation.
We tested the hypotheses H0 :  and H1 :  for all voxels in V based on 
FMEM and its corresponding voxel-wise method, and the score test based on the IBS kernel 
used in Ge et al. [2012]. Moreover, we evaluated their finite-sample performance in cluster-
based thresholding [Silver et al., 2011]. Specifically, we first thresholded the p-values for all 
voxels in V by using an initial p-value of 0.01 as suggested by Silver et al. [2011] in order to 
identify clusters of contiguous supra-threshold voxels. Then, the thresholded clusters were 
matched with the 9 true effect areas in Figure 3 (b) or (e). If a specific thresholded cluster 
overlaps with at least one voxel in any of the 9 true effect regions, we call such cluster as a 
“true positive”. In contrast, if a specific thresholded cluster does not overlap with any voxels 
of the 9 effect regions, we call a cluster a “false positive”. We summarized the hypothesis 
testing results by the average dice overlap ratio (DOR), the average number of false positive 
clusters, and the average size in the number of voxels of false positive clusters. DOR is the 
ratio between the number of true positive clusters over the true number of effect areas, 
which is 9 in this simulation setting. Thus, the higher DOR means the higher the probability 
of detecting the true effect regions.
As shown in Tables 3 and 4, if we set the cluster size threshold as one voxel, FMEM has 
smaller DOR and a smaller number of false positive clusters compared with the voxel-wise 
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method. When the cluster size threshold increases to 10 voxels, FMEM has a similar DOR 
value as that of the no threshold case, whereas the DOR of the voxel-wise approach reduces 
by about 20%. The score test based on the IBS kernel has little power to detect the nine 
effect regions with subtle effects. It may be caused by both the relatively low sensitivity of 
the score test itself and the misspecified IBS kernel.
Table 5 summarizes the number of significant voxels identified by the three methods in each 
effect region of Scenarios I and II. In Table 5, FMEM identifies less voxels in the non-effect 
regions, while detecting more voxels in the effect regions in both scenarios. For FMEM, its 
computational time is around 30 minutes for the first scenario and 20 minutes for the second 
one. Table 5 also confirms that the score test based on the IBS kernel has little statistical 
power in detecting the nine effect regions. Therefore, FMEM significantly outperforms the 
voxel-wise method and the score test based on the IBS kernel [Ge et al., 2012] in terms of 
detecting the true effect regions and controlling the false positive error rate.
3.2 ADNI Data Analysis
The ADNI study began in 2004 and has three phases thus far, including ADNI-1, ADNI GO, 
and ADNI-2. The overall objective of the ADNI study is to determine the relationships 
among the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of 
the entire spectrum of AD as the pathology evolves from normal aging through early mild 
cognitive impairment, to mild cognitive impairment, to late mild cognitive impairment, to 
dementia or AD. The Principal Investigator of this initiative is Dr. Michael W. Weiner, MD, 
VA Medical Center and University of California San Francisco. For up-to-date information, 
see www.adni-info.org for details.
The aim of this ADNI data analysis is to use FMEM to identify brain regions affected by 
candidate genes, thereby hoping to shed light on the pathological interactions between these 
candidate genes and brain structure and function. The data we employed to evaluate the 
performance of FMEM was from ADNI-1. About 800 subjects with age older than 65 were 
recruited and followed at least 3 years. The 800 subjects included 200 healthy controls, 400 
subjects with different levels of mild cognitive impairment (MCI), and 200 subjects with 
Alzheimer’s disease (AD). Besides the SNPs and the T1 weighted MRI imaging 
measurements, the subjects were assessed with demographic information and psychiatric 
examination scores to determine the diagnosis status at each scheduled visit.
The raw magnetic resonance image (MRI) data was collected from a variety of 1.5 Tesla 
MRI scanners with protocols individualized for each scanner, including standard T1-
weighted images obtained using volumetric 3-dimensional sagittal MPRAGE or equivalent 
protocols with varying resolutions. The typical protocol included: repetition time (TR) = 
2400 ms, inversion time (TI) = 1000 ms, flip angle = 80, field of view (FOV) = 24 cm, with 
a 256 × 256 × 170 acquisition matrix in the x-,y-, and z-dimensions yielding a voxel size of 
1.25 × 1.26 × 1.2 mm3.
The T1-weighted MRI images were preprocessed by standard image processing steps 
including AC (anterior commissure) and -PC (posterior commissure) correction, bias field 
correction, skull-stripping, intensity inhomogeneity correction, cerebellum removal, 
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segmentation, and nonlinear registration [Wang et al., 2011]. After segmentation, the brain 
was segmented into four different tissues: grey matter (GM), white matter (WM), ventricle 
(VN), and cerebrospinal fluid (CSF). We quantified the local volumetric group differences 
by generating RAVENS maps [Davatzikos et al., 2001] for the whole brain and each of the 
segmented tissue type (GM, WM, VN, and CSF) respectively, using the deformation field 
which we obtained during registration. RAVENS methodology is based on a volume-
preserving spatial transformation, since this process changes an individual[prime]s brain 
morphology to conform it to the morphology of the Jacob template.
We are interested in detecting meaningful brain regions of interest that are associated with 
several candidate genes. We included only the subjects whose diagnostic status was healthy 
control or Alzheimer’s disease at baseline and had no status change during ADNI1. After 
screening, the total number of subjects we included was 372 (195 Healthy Controls (HCs) 
and 177 ADs). The clinical covariates of interest included gender, baseline age, square of 
baseline age, handedness, education, baseline intracranial volume, and the risk of 
Apolipoprotein E (ApoE). Specifically, handedness was treated as a binary variable, the 
education information was the self-reported years of education by the subjects, and the risk 
of APOE is assumed to be additive. Specifically, the risk of APOE for a subject was 3 if 
he/she carries ε4 at both alleles; it was 2 if he/she carries ε3 and ε4 in two alleles, the risk 
would be considered 0 if the two APOE alleles were the combination of ε2 and ε3, and other 
combinations of APOE alleles are assumed to have risk 1.
Many genes have been reported to be causal in the progression of Alzheimer’s disease. We 
selected three candidate causal genes including CR1 on chromosome 1, CD2AP on 
chromosome 6, and PICALM on chromosome 11 due to their strong association with the 
progression of Alzheimer’s disease [Harold et al., 2009, Naj et al., 2011, Lambert et al., 
2009]. Specifically, PICALM encodes the protein phosphatidylinositol-binding clathrin 
assembly and is highly correlated with the emergence of late-on-set AD, which is possibly 
due to the perturbation at synapse triggering its function change [Harold et al., 2009]. The 
gene CD2AP encodes the CD2-asscociated protein and involves in the process of cell 
membrane, including endocytosis, that plays critical roles in neurodegeneration and Aβ 
clearance from the brain [Naj et al., 2011]. The gene CR1 encodes the complement 
component (3b/4b) receptor 1 and the pathways involving CR1 are involved in the AD 
process, specifically in clearance of Aβ peptides, which is the primary composition of 
amyloid plaques [Lambert et al., 2009].
We first matched the SNPs in ADNI with the gene list “glist-hg18” provided by PLINK 
[Purcell and et al, 2007] and were able to locate 16, 15, and 23 SNPs on the selected CR1, 
CD2AP, and PICALM genes, respectively. All these SNPs pass the quality control 
procedure with MAF > 5% and the Hardy Weinberg Equilibrium (HWE) test p-value> 0.01. 
The MAFs of the SNPs of the selected genes vary from 0.1 to 0.5. After deleting missing 
values, there are 335, 299 and 328 subjects corresponding to the CR1, CD2AP, and 
PICALM genes, respectively. The MAFs of all selected SNPs and demographic information 
are included in the supplementary document.
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For each selected gene, we fitted FMEM (1) with z coded as the number of minor alleles in 
order to detect its associated brain regions of interest (ROIs). For comparisons, we fitted the 
same model by using the classical voxel-wise method and Ge’s method to the same data 
sets. To formally detect significant ROIs, by following Ge et al. [2012], we used a cluster-
form of threshold of 0.1% with a minimum voxel clustering value of 50 voxels. The names 
of the brain regions were included in Tables 6-8 of the supplementary document. FMEM is 
able to to detect 45, 45, and 27 significant clusters for CR1, CD2AP, and PICALM, 
respectively, whereas the standard voxel-wise method can only identify 6, 14, and 2 
significant clusters, and none from Ge’s method for CR1, CD2AP, and PICALM, 
respectively. We also fitted FMEM on the same data but only with the HC and AD samples 
only to investigate white noise signal. For HC samples only, FMEM detected 15, 8 and 31 
significant clusters for CR1, CD2AP and PICALM, respectively. For AD samples only, 
FMEM detected 9, 8 and 41 significant clusters for CR1, CD2AP and PICALM, 
respectively. Although there are some discrepancies between the results based on the HC 
and AD samples only and those based on the combined sample, the results are highly similar 
to each other. The results obtained from the combined sample are generally more significant 
due to a larger sample size.
Finally, we overlapped these significant clusters with the 96 predefined ROIs in the Jacob 
template and were able to detect several predefined ROIs for CR1, CD2AP, and PICALM. 
For CD2AP, based on the combined sample, FMEM identified relatively large clusters with 
more than 150 voxels of right superior temporal gyrus, left and right inferior temporal gryus, 
left and right precentral gyrus, left and right middle frontal gyrus, right postcentral gyrus, 
right fusiform, left angular, left inferior frontal gyrus, left inferior occipital gyrus, left and 
right postcentral gyrus, left and right superior frontal gyrus, left anterior cingulate and 
paracingulate gyri, left median cingulate and paracingulate gyri, right calcarine fissure and 
surrounding cortex, right cuneus, right superior occipital gyrus, right middle occipital gyrus, 
right caudate, and right middle temporal gyrus.
For CR1, based on the combined sample, FMEM identified relatively large clusters with 
more than 150 voxels of right superior temporal gyrus, left and right putamen, left inferior 
temporal gyrus, left angular, left inferior occipital gyrus, right postcentral gyrus, right 
superior frontal gyrus, left anterior cingulate and paracingulate gyri, left median cingulate 
and paracingulate gyri, left cuneus, left middle occipital gyrus, and right caudate.
For PICALM, based on the combined sample, FMEM identified relatively large clusters 
with more than 150 voxels of right inferior frontal gyrus- triangular and orbital parts, right 
insula, right fusiform, right superior temporal gyrus, right temporal pole, right middle 
temporal gyrus, right inferior temporal gyrus, right precentral gyrus, right supramarginal 
gyrus, right middel occipital gyrus, right angular, right middle frontal gyrus, and right 
middle frontal gyrus.
As shown in the supplementary document, we were able to detect several major ROIs, such 
as superior temporal gyrus, inferior temporal gyrus, middle frontal gyrus, angular, anterior 
cingulate and paracingulate gyri, hippocampus, putamen, and fusiform. Our finding of these 
ROIs are highly similar to previous reports on brain morphology in Alzheimer’s disease in 
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the AD literature [Ohnishi et al., 2001, Convit et al., 2000, Jones et al., 2006, Fennema-
Notestine et al., 2009]. The superior temporal gyrus is an essential structure involved in 
auditory processing, in social cognition processes, as well as in the function of language. 
The inferior temporal gyrus is one of the higher levels of the ventral stream of visual 
processing. The middle frontal gyrus plays a role in sustaining attention and working 
memory. The angular gyrus is involved in a number of processes related to language, 
number processing and spatial cognition, memory retrieval, attention, and theory of mind. 
The anterior cingulate and paracingulate gyri in rational cognitive functions, such as reward 
anticipation, decision-making, empathy, impulse control, and emotion. The hippocampus is 
known to be associated with memory and cognition. The fusiform is associated with color 
recognition, word and body recognition and the putamen is associated with motor skills. 
Figure 4 shows the −log10(p) map of selected slices with significant clusters for testing the 
genetic effects of CD2AP on RAVEN images identified by FMEM.
4 Discussion
We have developed FMEM to carry out an association analysis between neuroimaging 
phenotypes and a group of genetic markers, while adjusting for the clinical variables of 
interest. We have proposed a multiscale adaptive procedure with three features: spatial, 
hierarchical, and adaptive. Our simulation results have shown substantial gains in parameter 
estimation precision and statistical power in detecting the true effect of ROIs compared to 
the voxel-wise method. More research is needed for optimizing the choice of the tuning 
parameters in FMEM. We will borrow some key ideas of FMEM to develop a fast procedure 
to carry out GWAS for imaging genetic studies. We will also develop fast FMEM for the 
joint analysis of neuroimaging and genetic data with rare or common variants [Fan et al., 
2013, 2012].
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Simulation setting: (a) True image of β0; (b) true image of β1, in which the colors represent 
the values of β1(v) × 104; (c) true image of β2; and (d) true image of β3.
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Simulation results for estimation accuracy: Scenario I: (a) estimated  by using voxel-
wise approach; (b) true  image; and (c) estimated  by using FMEM. Scenario II: 
(d) estimated  by using voxel-wise approach; (e) true  image; (f) estimated 
by using FMEM.
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Simulation results for testing the genetic effects: Scenario I: the rejection rate image at a 
selected slice by using (a) voxel-wise approach and (b) FMEM; Scenario II: the rejection 
rate image by using (c) voxel-wise approach and (d) FMEM.
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ADNI data analysis: the −log10(p) maps for testing the genetic effect of CD2AP on RAVEN 
images by using FMEM from 14 selected slices.
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Table 1
Simulation results: the estimation results of  in Scenario I using FMEM and the voxel-wise method in 
terms of average absolute value of bias (BIAS), root mean square error (RMS), standard deviation (SD), and 
the ratio between RMS and SD (RE).
FMEM Voxel-wise
σγ
2(v) |BIAS| RMS SD RE |BIAS| RMS SD RE
0 0.001 0.002 0.002 1 0.007 0.005 0.005 1
0.005 2.36e-06 0.003 0.003 1 0.005 0.005 0.005 1
0.0075 0.0005 0.003 0.003 1 0.005 0.006 0.006 1
0.01 0.001 0.004 0.004 1 0.006 0.008 0.008 1
0.0125 0.001 0.004 0.004 1 0.006 0.008 0.008 1
0.015 0.002 0.005 0.005 1 0.008 0.010 0.010 1
0.0175 0.003 0.005 0.005 1 0.008 0.010 0.010 1
0.020 0.002 0.006 0.006 1 0.010 0.012 0.012 1
0.0225 0.003 0.006 0.006 1 0.010 0.013 0.013 1
0.025 0.004 0.006 0.006 1 0.010 0.014 0.014 1
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Table 2
Simulation results: the estimation results of  in Scenario II by using FMEM and the voxel-wise method 
in terms of average absolute value of bias (BIAS), root mean square error (RMS), standard deviation (SD), 
and the ratio between RMS and SD (RE).
FMEM Voxel-wise
σγ
2(v) |BIAS| RMS SD RE |BIAS| RMS SD RE
0 0.002 0.003 0.003 1 0.003 0.008 0.008 1
0.005 0.0001 0.004 0.004 1 0.007 0.126 0.126 1
0.010 0.001 0.006 0.006 1 0.011 0.016 0.016 1
0.015 0.002 0.008 0.008 1 0.014 0.020 0.02 1
0.020 0.002 0.010 0.010 1 0.024 0.017 0.017 1
0.025 0.003 0.020 0.020 1 0.020 0.029 0.029 1
0.030 0.005 0.013 0.013 1 0.023 0.032 0.032 1
0.035 0.004 0.014 0.014 1 0.026 0.035 0.035 1
0.040 0.015 0.006 0.006 1 0.028 0.040 0.040 1
0.045 0.007 0.016 0.016 1 0.031 0.040 0.040 1
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Table 3
Simulation results: comparisons of FMEM, voxel-wise method, and the score test based on the IBS kernel 
(Score) for Scenario I: the dice overlap ratio (DOR), average number of false positive clusters, and average 
size of false positive clusters with different cluster size thresholds.
FMEM Voxel-wise Score
Threshold Mean SD Mean SD Mean SD
Scenario I
DOR 0.94 0.05 0.99 0.02 0 0
Voxel Size = 1 False Positive Cluster Number 1.88 6.12 21.30 12.29 0 0
False Positive Cluster Size 1.03 0.04 1.06 0.06 NA NA
DOR 0.91 0.04 0.83 0.10 0 0
Voxel Size = 10 False Positive Cluster Number 0 0 0 0 0 0
False Positive Cluster Size NA NA NA NA NA NA
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Table 4
Simulation results: comparisons of FMEM, voxel-wise method, and the score test based on the IBS kernel 
(Score) for Scenario II: the dice overlap ratio (DOR), average number of false positive clusters, and average 
size of false positive clusters for Scenario II with different cluster size thresholds.
FMEM Voxel-wise Score
Threshold Mean SD Mean SD Mean SD
Scenario II
DOR 0.86 0.06 0.996 0.02 0.49 0.21
Voxel Size = 1 False Positive Cluster Number 1.35 4.85 15.45 12.92 0 0
False Positive Cluster Size 1.07 0.08 1.05 0.07 NA NA
DOR 0.85 0.07 0.78 0.11 0.01 0.03
Voxel Size = 10 False Positive Cluster Number 0 0 0 0 0 0
False Positive Cluster Size NA NA NA NA NA NA
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